Technology shapes patient care and new therapies

Ever wonder how technology will impact patient care in the future? Our industry is changing, with advancing technology driving innovation and patient care. Technology is also hugely expanding the amount of data collected, shared and analyzed. New technologies will transform clinical research to facilitate a more personalized and patient-centric approach to drug development. Innovated technology is currently being used to deliver healthcare to reach new patients and to better meet current patient needs.

Whether you are a technology guru, drug developer or patient care advocate, current and future technologies will impact how we do business and how we serve our patients. Does access to information change patient involvement in their healthcare? Does the prevalence of smartphones impact data that are collected and available? Do these mobile devices affect patient behaviors? How do new technologies potentially change the highly regulated healthcare field?

The HBA Metro chapter evening event on June 26 will dive into the changing technology landscape in our industry. A panel of leaders in healthcare will discuss the impact of technology on healthcare, today and in the future. Be a part of the event and help to foster dialogue on the collaboration required to break out of current models of healthcare delivery.

Event title: Driving Innovation and Accelerating Value: How Technology is Shaping Patient Care and New Therapies
Event details: Thursday, June 26, 2014, 5:30 - 8:30 PM, New York, NY
Event Location: Medidata Solutions
 350 Hudson Street, 9th Floor Café/Roof Deck
  New York, New York 10014

Kara Dennis, chief of staff, Medidata Solutions  

As chief of staff, Kara oversees Medidata’s priority strategic initiatives to advance clinical trials and accelerate internal efforts. Kara works with the CEO and president to identify and define opportunities, and has executional responsibility for a targeted set of special projects. In her former role as Medidata’s VP of corporate strategy, Kara was responsible for developing a company-wide strategy for the board of directors and the internal organization. Prior to joining Medidata in 2012, Kara spent four years at McKinsey & Company consulting for life science and healthcare provider clients. She led a wide range of projects, including M&A, R&D portfolio analysis and biopharma commercial strategy. Kara then moved to Ikaria, a private equity-backed biotech company in the critical care space, working with the business development group to acquire new therapies. She joined Medidata after recognizing the benefits that intelligent application of technology could bring to clinical trials. Kara continues to see enormous opportunity for advancement in clinical development and, ultimately, great potential to bring better therapies to patients. Kara holds a BA from Yale University and an MBA from Harvard Business School. 

Michael A. Ibara, PharmD, head of business development coordination and innovation, Pfizer

Michael Ibara is head of business development coordination and innovation at Pfizer and one of his responsibilities is to research and assess innovative models for drug safety. His career has been focused on the interface between healthcare, technology and industry as it applies to pharmacovigilance and related disciplines. He was head of drug safety for a Biotech company specializing in oncology and AIDS drugs. At Pfizer, he led implementation of a global safety electronic submissions system and has managed the implementation of large-scale safety technologies. Five years ago, he began research on the implications of digitized healthcare data on pharmacovigilance practice and drug safety, specifically with the goal of developing a new business model for pharmacovigilance which will contribute to improved public health. This led to him designing and co-leading the ASTER project, which was the first time adverse events were retrieved directly from an electronic health record and delivered to FDA. He received his PharmD degree from the University of Michigan and completed a fellowship in drug research and development with Burroughs Wellcome, Inc. and the University of North Carolina.

Michelle Marlborough, vice president, product strategy, Medidata Solutions  
As vice president of product strategy, Michelle is responsible for product direction across the entire Medidata Clinical Cloud™. Michelle works with Medidata’s development team of over 200 people in creating new modules and capabilities within Medidata’s cloud-based platform, incorporating data-driven analytics and ensuring proper functionality and a better user experience. Michelle began her career in the UK in data management and technical standards at Glaxo Wellcome (now GlaxoSmithKline) and AstraZeneca. Drawing on over 15 years of experience in life sciences and software development, Michelle stands at the intersection of clinical trials and technology. Michelle is a passionate proponent of the role technology can play in improving clinical research, exploring how cloud-based platforms can improve clinical research and assessing the organizational requirements of an engineering culture to deliver such a platform. Michelle holds a BS in biology and mathematics from Coventry University in the UK.

Tammy Warner, head of global commercial IT, Celgene
Tammy is a dynamic business information technology leader with experience as a member of corporate leadership teams – delivering ambitious systems solutions and programs aligned with organizational priorities. She has a track record of leading from insight to execution, in local and globally matrixed environments and is skilled in IT transformation of departments, programs, projects and processes, and creating service excellence. She currently works at Celgene in the global information technology department and has background in diverse organizations ranging from small entrepreneurial to Fortune 500, in pharmaceutical, consumer and consulting, having work for Novartis, Schering-Plough, Cap Gemini, Lenox China Crystal and Alpo. Tammy holds an MBA from Lehigh University and a BA from DeSales University. She gives back by volunteering in her industry including NJ Society for Information Management and the Healthcare Businesswomen’s Association, and various community organizations.

Jeanne Zucker, vice president client development, Athenahealth
Jeanne serves as vice president client development within the enterprise division at athenahealth, a leading provider of cloud-based services for electronic health record (EHR), practice management and care coordination for physician practices, health systems, retail clinics and urgent care centers. Jeanne provides service support for athena’s largest clients. Prior to athena, Jeanne held the position of senior vice president, client relations for InfoMedics, Inc., based in Reading, MA, a healthcare services organization focused on patient feedback and support programs for the pharmaceutical industry. Before moving into the pharmaceutical industry, Jeanne was with Private Healthcare Systems, Inc. within the managed care industry, where her progressive leadership roles culminated in her role as vice president, network services. Jeanne holds an undergraduate degree in psychobiology and neurobiology from Wellesley College. Jeanne has held numerous roles at the HBA chapter and association board level including first vice president in 2012, president-elect in 2013, and now president of the association in 2014.

Thank you to our sponsor

News Categories: 
Groups audience: